What people are saying - Write a review
We haven't found any reviews in the usual places.
Risks and Benefits of Aromatase Inhibitors in Postmenopausai Breast Cancer
A Review of their Pharmacology
3 other sections not shown
activity adjuvant advanced breast cancer agents aminoglutethimide anastrozole antigen aromatase inhibitors axillary breast cancer breast cancer abstract breast cancer patients Breast Cancer Res breast tumours Cancer Res Treat chemotherapy Clin Oncol 1996 clinical trials combination cyclophosphamide cytotoxic disease docetaxel dose doxorubicin drug edatrexate effects efficacy endocrine therapy enzyme estrogen evaluation exemestane expression fadrozole first-line fluorouracil formestane gemcitabine gene therapy growth factor human breast cancer immune Immunol immunotherapy infusion inhibition Int J Cancer kinase letrozole liposomal lymph nodes lymphocytes malignant mammary tumor mastectomy megestrol metastatic breast cancer monoclonal antibody mucin murine Natl Cancer Inst Oncology oral overexpression paclitaxel Pathol patients with advanced patients with breast patients with metastatic pharmacokinetic phase II study phase II trial postmenopausal women Proc Am Soc prodrug prognostic protein radiotherapy randomised receptor relapse response rate second-line Soc Clin Oncol Soc Oncol Suppl surgery survival tamoxifen therapeutic tissue topotecan toremifene toxicity tumour vinorelbine vitro vivo